{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:35:03Z","timestamp":1774596903029,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Il Farmaco"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.farmac.2004.03.012","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T00:34:56Z","timestamp":1091666096000},"page":"729-738","source":"Crossref","is-referenced-by-count":10,"title":["The ICH guidance in practice: stress degradation studies on indinavir sulphate and development of a validated specific stability-indicating HPTLC assay method"],"prefix":"10.1016","volume":"59","author":[{"given":"Neeraj","family":"Kaul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himani","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Paradkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.R.","family":"Mahadik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farmac.2004.03.012_BIB1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2165\/00003088-199732030-00003","article-title":"Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations","volume":"32","author":"Barry","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.farmac.2004.03.012_BIB2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.1997.03540260059037","article-title":"Thrombolytic therapy for eligible elderly patient with acute myocardial infarction","volume":"277","author":"Deeks","year":"1997","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.farmac.2004.03.012_BIB3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-4347(97)00421-0","article-title":"Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography","volume":"703","author":"Burger","year":"1997","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0378-4347(97)00607-5","article-title":"Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma","volume":"707","author":"Jayewardene","year":"1998","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-4347(98)00451-4","article-title":"Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection","volume":"721","author":"Foisy","year":"1999","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0731-7085(99)00288-5","article-title":"LC determination of indinavir in biological matrices with electrochemical detection","volume":"22","author":"Fizzano","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.farmac.2004.03.012_BIB7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0378-4347(99)00342-4","article-title":"Determination of indinavir in human cerebrospinal fluid and plasma by solid-phase extraction and high-performance liquid chromatography with column switching","volume":"734","author":"Zhong","year":"1999","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0731-7085(98)00048-X","article-title":"Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection","volume":"18","author":"Woolf","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.farmac.2004.03.012_BIB9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0731-7085(00)00506-9","article-title":"An LC\u2013MS\u2013MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma","volume":"25","author":"Jayewardene","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.farmac.2004.03.012_BIB10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-4347(98)00392-2","article-title":"Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection","volume":"719","author":"van Heeswijk","year":"1998","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-4347(99)00573-3","article-title":"Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction","volume":"740","author":"Marzolini","year":"2000","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0731-7085(00)00420-9","article-title":"High-throughput simultaneous determination of the HIV protease inhibitors indinavir and L-756423 in human plasma using semi-automated 96-well solid phase extraction and LC-MS\/MS","volume":"24","author":"Rose","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.farmac.2004.03.012_BIB13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-4347(01)00117-7","volume":"758","author":"Dailly","year":"2001","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-4347(99)00079-1","article-title":"Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography","volume":"727","author":"Hugen","year":"1999","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-4347(99)00388-6","article-title":"High-performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patients during highly active antiretroviral therapy","volume":"735","author":"Langmann","year":"1999","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-4347(00)00225-5","article-title":"Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography","volume":"744","author":"Aymard","year":"2000","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-4347(00)00617-4","article-title":"Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography","volume":"755","author":"Yamada","year":"2001","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0378-4347(01)00172-4","article-title":"Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography","volume":"757","author":"Nacenta","year":"2001","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0021-9673(00)01092-X","article-title":"Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography","volume":"913","author":"Simon","year":"2001","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.farmac.2004.03.012_BIB20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1570-0232(02)00295-7","article-title":"Simultaneous determination of indinavir, ritonavir and lopinavir (ABT 378) in human plasma by high-performance liquid chromatography","volume":"775","author":"Ray","year":"2002","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1570-0232(02)00140-X","article-title":"Study of different off-line sample processing procedures and the measurement of antibiotic and antiviral levels in human serum by high-performance liquid chromatography","volume":"773","author":"Metz","year":"2002","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1570-0232(02)00728-6","article-title":"Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography","volume":"783","author":"Justesen","year":"2003","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1570-0232(02)00822-X","article-title":"Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography","volume":"784","author":"Turner","year":"2003","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.farmac.2004.03.012_BIB24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0731-7085(02)00357-6","article-title":"Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC\/MS\/MS","volume":"30","author":"Chi","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.farmac.2004.03.012_BIB25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0731-7085(03)00530-2","article-title":"Capillary electrophoretic method for determination of protease inhibitor indinavir sulphate used in human immunodeficiency virus therapy","volume":"34","author":"Aurora Prado","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.farmac.2004.03.012_BIB26","year":"1993"},{"key":"10.1016\/j.farmac.2004.03.012_BIB27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/jaoac\/84.4.1265","article-title":"Validation and Quality Assurance of planar chromatography procedures in Pharmaceutical Analysis","volume":"84","author":"Ferenczi-Fodor","year":"2001","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.farmac.2004.03.012_BIB28","first-page":"336","article-title":"Planar Chromatography\u2014A Retrospective View from the Third Millennium (Sz. Nyiredy Edt.)","author":"Ferenczi-Fodor","year":"2001"},{"key":"10.1016\/j.farmac.2004.03.012_BIB29","series-title":"Thin layer chromatography, Monograph 2.2.27, European Pharmacopoeia","first-page":"3638","year":"2002"},{"key":"10.1016\/j.farmac.2004.03.012_BIB30","year":"1994"},{"key":"10.1016\/j.farmac.2004.03.012_BIB31","year":"1996"},{"key":"10.1016\/j.farmac.2004.03.012_BIB32","year":"2002"},{"key":"10.1016\/j.farmac.2004.03.012_BIB33","series-title":"High Performance Thin Layer Chromatography, Quantitative Analysis of Pharmaceutical Formulations","author":"Sethi","year":"1996"},{"key":"10.1016\/j.farmac.2004.03.012_BIB34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jps.3030440817","article-title":"Chemical stability of pharmaceuticals","volume":"44","author":"Garrett","year":"1955","journal-title":"J. Am. Pharm. Assoc. Sci."},{"key":"10.1016\/j.farmac.2004.03.012_BIB35","series-title":"Drug Stability Principles and Practices","author":"Carstensen","year":"2000"}],"container-title":["Il Farmaco"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014827X0400103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014827X0400103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T22:43:43Z","timestamp":1585867423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014827X0400103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0014827X0400103X"],"URL":"https:\/\/doi.org\/10.1016\/j.farmac.2004.03.012","relation":{},"ISSN":["0014-827X"],"issn-type":[{"value":"0014-827X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}